Search Within

Shanu Modi

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (36)
  3. Research Letter (1)
Groups
  1. Breast Medicine Service (76)
  2. Department of Medicine (76)
  3. Epidemiology and Biostatistics (76)
  4. Solid Tumor Oncology Division (76)
  5. Survivorship Research (70)
  6. Biostatistics Service (67)

More Groups

People
  1. Clifford Hudis (50)
  2. Sujata Patil (44)
  3. Larry Norton (38)
  4. Chau Dang (31)
  5. Sarat Chandarlapaty (28)
  6. Diana Lake (27)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (4)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Cancer Research (16)
  3. Clinical Breast Cancer (6)
  4. Clinical Cancer Research (4)
  5. npj Breast Cancer (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (22)
  2. American Society of Clinical Oncology (20)
  3. Elsevier Inc. (9)
  4. Nature Publishing Group (6)
  5. Oxford University Press (6)
  6. American Medical Association (3)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen receptor-positive (AR plus ) TNBC
    Meeting Abstract

    Traina, T. A.; Boyle, L. A.; Arumov, A.; Patil, S.; Edelweiss, M.; DeFusco, P. A.; Gorsky, M.; Lamparella, N. E.; Modi, S.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients
    Meeting Abstract

    Chan, D.; Freites Martinez, A. D.; Goldfarb, S. B.; Modi, S.; Gajria, D.; Lacouture, M. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia
    Journal Article

    Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save